BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12648789)

  • 1. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants.
    Horwitz EM; Mitra RK; Uzzo RG; Das IJ; Pinover WH; Hanlon AL; McNeeley SW; Hanks GE
    Radiother Oncol; 2003 Feb; 66(2):173-9. PubMed ID: 12648789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment margins for prostate brachytherapy.
    Han B; Wallner K; Aggarwal S; Armstrong J; Sutlief S
    Semin Urol Oncol; 2000 May; 18(2):137-41. PubMed ID: 10875455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis.
    Merrick GS; Butler WM; Wallner KE; Blasko JC; Michalski J; Aronowitz J; Grimm P; Moran BJ; McLaughlin PW; Usher J; Lief JH; Allen ZA
    Brachytherapy; 2005; 4(4):241-51. PubMed ID: 16344253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.
    Lee WR; deGuzman AF; Bare RL; Marshall MG; McCullough DL
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):83-8. PubMed ID: 10656377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning technique.
    Zelefsky MJ; Yamada Y; Cohen G; Venkatraman ES; Fung AY; Furhang E; Silvern D; Zaider M
    Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):601-8. PubMed ID: 10974481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of planning margin on dosimetric quality in 131Cs permanent prostate brachytherapy.
    Li T; Fountain BL; Duffy EW
    Brachytherapy; 2010; 9(2):159-64. PubMed ID: 19853535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric evaluation of clinical target volume in the postimplant analysis of low-dose-rate brachytherapy for prostate cancer.
    Nasser NJ; Sappiatzer J; Wang Y; Borg J; Saibishkumar EP
    Brachytherapy; 2015; 14(2):189-96. PubMed ID: 25301338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants.
    Moerland MA; van Deursen MJ; Elias SG; van Vulpen M; Jürgenliemk-Schulz IM; Battermann JJ
    Radiother Oncol; 2009 May; 91(2):202-6. PubMed ID: 18950884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study.
    Salem N; Simonian-Sauve M; Rosello R; Alzieu C; Gravis G; Maraninchi D; Bladou F
    Radiother Oncol; 2003 Feb; 66(2):159-65. PubMed ID: 12648787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a preferred strength for regularly spaced 125I seeds in inverse-planned prostate implants?
    Sloboda RS; Pedersen JE; Halperin R
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):234-44. PubMed ID: 12504058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of three-dimensional radiation therapy planning tools and intraoperative ultrasound to evaluate high dose rate prostate brachytherapy implants.
    Kini VR; Edmundson GK; Vicini FA; Jaffray DA; Gustafson G; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):571-8. PubMed ID: 10078639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines.
    Croke J; Maclean J; Nyiri B; Li Y; Malone K; Avruch L; Kayser C; Malone S
    Radiat Oncol; 2014 Dec; 9():303. PubMed ID: 25534278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Dose and Quality Assurance in Early Prostate Cancer Treated with Low Dose Rate Brachytherapy as Monotherapy.
    Henry AM; Rodda SL; Mason M; Musunuru H; Al-Qaisieh B; Bownes P; Smith J; Franks K; Carey B; Bottomley D
    Clin Oncol (R Coll Radiol); 2015 Jul; 27(7):382-6. PubMed ID: 25805312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
    Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
    Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor predictive value of intraoperative real-time dosimetry for prostate seed brachytherapy.
    Igidbashian L; Donath D; Carrier JF; Lassalle S; Hervieux Y; David S; Bahary JP; Taussky D
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):605-9. PubMed ID: 18793964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is intraoperative nomogram-based overplanning of prostate implants necessary?
    D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy in patients with small prostate glands.
    Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
    Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary morbidity with a modified peripheral loading technique of transperineal (125)i prostate implantation.
    Brown D; Colonias A; Miller R; Benoit R; Cohen J; Arshoun Y; Galloway M; Karlovits S; Wu A; Johnson M; Quinn A; Kalnicki S
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):353-60. PubMed ID: 10802359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
    Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.